After Glybera's withdrawal, what's next for gene therapy?
Melanie Senior(Unknown)
Cited by 114
Related Papers
Novartis signs up for Google smart lens
|Nature Biotechnology|2014|152
Fresh from the biotech pipeline: fewer approvals, but biologics gain share
|Nature Biotechnology|2023|64
Checkpoint inhibitors go viral
|Nature Biotechnology|2019|39
Cancer-targeting antibody–drug conjugates drive dealmaking frenzy
|Nature Biotechnology|2024|28
Fresh from the biotech pipeline: record-breaking FDA approvals
|Nature Biotechnology|2024|25